238
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Distribution of CD4+CD25highFoxP3+ regulatory T-cells in umbilical cord blood

, , , , , , & show all
Pages 2058-2061 | Received 30 Dec 2011, Accepted 10 Feb 2012, Published online: 02 May 2012
 

Abstract

Objective: This study aimed to establish reference intervals for lymphocyte subsets including CD4+CD25highFoxP3+ regulatory T-cells (Tregs) in umbilical cord blood. Methods: Umbilical cord blood was obtained after birth from 120 healthy full-term neonates, who were born between November 2010 and November 2011. Lymphocyte subsets including Tregs were analysed using flow cytometer (Beckman Coulter, Fullerton, CA, USA), and the reference intervals were defined using non-parametrical percentile methods according to the Clinical and Laboratory Standard Institute guideline (C28-A3). Results: The reference intervals for lymphocyte subsets were: helper T-cells (CD3+/CD4+), 15.40–70.06%; cytotoxic T-cells (CD3+/CD8+), 9.65–34.28%; B-cells (CD19+), 4.50–29.59%; and natural killer cells (CD3/CD16+/CD56+), 1.42–28.03%. The reference interval for Tregs was 0.35–9.07%. Conclusions: This study provides the reference intervals for lymphocyte subsets including Tregs in umbilical cord blood from healthy full-term neonates. These results could be used as fundamental data for clinical laboratory tests as well as future researches.

Declaration of Interest: This study was supported by Konkuk University in 2012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.